BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24300013)

  • 21. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.
    Aalten J; Bemelman FJ; van den Berg-Loonen EM; Claas FH; Christiaans MH; de Fijter JW; Hepkema BG; Hené RJ; van der Heide JJ; van Hooff JP; Lardy NM; Lems SP; Otten HG; Weimar W; Allebes WA; Hoitsma AJ
    Nephrol Dial Transplant; 2009 Aug; 24(8):2559-66. PubMed ID: 19474284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
    Akgul SU; Ciftci HS; Temurhan S; Caliskan Y; Bayraktar A; Tefik T; Kaya IA; Canitez IO; Demir E; Yazici H; Bakkaloglu H; Aydin AE; Turkmen A; Nane I; Aydin F; Oguz FS
    Transplant Proc; 2017 Apr; 49(3):425-429. PubMed ID: 28340805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low transplantability of 0 blood group and highly sensitized candidates in the Portuguese kidney allocation algorithm: quantifying an old problem in search of new solutions.
    Tafulo S; Malheiro J; Dias L; Mendes C; Osório E; Martins LS; Santos J; Pedroso S; Almeida M; Castro-Henriques A
    HLA; 2016 Nov; 88(5):232-238. PubMed ID: 27647555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status.
    Karahan GE; Kekik C; Oguz FS; Onal AE; Bakkaloğlu H; Calişkan YK; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
    Ren Fail; 2010 Jan; 32(3):380-3. PubMed ID: 20370456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential risk factors for hypersensitization reflected by panel-reactive antibodies in dialysis patients.
    Pour-Reza-Gholi F; Daneshvar S; Nafar M; Firouzan A; Farrokhi F; Einollahi B
    Transplant Proc; 2005 Sep; 37(7):2936-8. PubMed ID: 16213266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.
    Lagaaij EL; Hennemann IP; Ruigrok M; de Haan MW; Persijn GG; Termijtelen A; Hendricks GF; Weimar W; Claas FH; van Rood JJ
    N Engl J Med; 1989 Sep; 321(11):701-5. PubMed ID: 2671729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of donor-specific anti-human leukocyte antigen antibodies after the transplantation of a fully matched kidney allograft and its impact on the selection of a subsequent renal regraft: a case report.
    Schlaf G; Radam C; Wahle A; Altermann WW
    Transplant Proc; 2012 Jun; 44(5):1442-5. PubMed ID: 22664032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States.
    Tague LK; Witt CA; Byers DE; Yusen RD; Aguilar PR; Kulkarni HS; Bain KB; Fester KA; Puri V; Kreisel D; Mohanakumar T; Trulock EP; Hachem RR
    Ann Am Thorac Soc; 2019 Jul; 16(7):846-852. PubMed ID: 30763122
    [No Abstract]   [Full Text] [Related]  

  • 32. Red blood cell transfusion use in patients with chronic kidney disease.
    Gill KS; Muntner P; Lafayette RA; Petersen J; Fink JC; Gilbertson DT; Bradbury BD
    Nephrol Dial Transplant; 2013 Jun; 28(6):1504-15. PubMed ID: 23389999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive red blood cell transfusions and risk of alloimmunization.
    Zalpuri S; Middelburg RA; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG; Zwaginga JJ
    Transfusion; 2014 Feb; 54(2):278-84. PubMed ID: 23782244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients.
    Marfo K; Ling M; Bao Y; Calder B; Ye B; Hayde N; Greenstein S; Chapochnick-Friedman J; Glicklich D; de Boccardo G; Kinkhabwala M; Akalin E
    Transplantation; 2012 Aug; 94(4):345-51. PubMed ID: 22820699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of anti-HLA antibodies in sensitized kidney transplant candidates subjected to desensitization with intravenous immunoglobulin and rituximab.
    Lobashevsky AL; Higgins NG; Rosner KM; Mujtaba MA; Goggins WC; Taber TE
    Transplantation; 2013 Jul; 96(2):182-90. PubMed ID: 23778648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA sensitization in ventricular assist device recipients: does type of device make a difference?
    Kumpati GS; Cook DJ; Blackstone EH; Rajeswaran J; Abdo AS; Young JB; Starling RC; Smedira NG; McCarthy PM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1800-7. PubMed ID: 15173739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart transplant graft survival is improved after a reduction in panel reactive antibody activity.
    Schaffer JM; Singh SK; Reitz BA; Oyer PE; Robbins RC; Mallidi HR
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):555-64; discussion 564-5. PubMed ID: 23246047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia.
    Sypek MP; Kausman JY; Watson N; Wyburn K; Holt SG; Hughes P; Clayton PA
    Transplantation; 2021 Jun; 105(6):1317-1325. PubMed ID: 34019363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates.
    Karpinski M; Pochinco D; Dembinski I; Laidlaw W; Zacharias J; Nickerson P
    J Am Soc Nephrol; 2004 Mar; 15(3):818-24. PubMed ID: 14978185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex.
    Yang J; Schall C; Smith D; Kreuser L; Zamberlan M; King K; Gajarski R
    J Heart Lung Transplant; 2009 Feb; 28(2):123-9. PubMed ID: 19201336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.